The Apolipoprotein E isoform E4 (ApoE4) is consistently associated with an elevated risk of developing late-onset Alzheimer’s Disease (AD); however, less is known about the potential genetic modulation of the brain networks organization during prodromal stages like Mild Cognitive Impairment (MCI). To investigate this issue during this critical stage, we used a dataset with a cross-sectional sample of 253 MCI patients divided into ApoE4-positive (‛Carriers’) and ApoE4-negative (‘non-Carriers’). We estimated the cortical thickness (CT) from high-resolution T1-weighted structural magnetic images to calculate the correlation among anatomical regions across subjects and build the CT covariance networks (CT-Nets). The topological properties of CT-Nets were described through the graph theory approach. Specifically, our results showed a significant decrease in characteristic path length, clustering-index, local efficiency, global connectivity, modularity, and increased global efficiency for Carriers compared to non-Carriers. Overall, we found that ApoE4 in MCI shaped the topological organization of CT-Nets. Our results suggest that in the MCI stage, the ApoE4 disrupting the CT correlation between regions may be due to adaptive mechanisms to sustain the information transmission across distant brain regions to maintain the cognitive and behavioral abilities before the occurrence of the most severe symptoms.
Late-onset Alzheimer’s Disease (AD) is a degenerative brain disease and the most common form of dementia in late-life, affecting millions of people worldwide1. Because of the lack of treatment, identifying causal risk factors at the early stages is paramount in clinical investigation. Most of the research is focusing its attention on the Mild Cognitive Impairment (MCI) stage. MCI is considered an intermediate phase between normal aging and AD. It is mainly characterized by a decline in cognitive abilities that do not interfere with daily functioning2. These patients are at increased risk of developing AD or another dementia1. Epidemiological research suggests an estimated 40% to 60% of MCI individuals aged 58 years and older have underlying AD pathology3,4.
Nevertheless, MCI does not always lead to dementia; some patients remain stable or revert to a normal state while other progress to different brain pathologies. This clinical variability is based on the interplay between physiological, environmental, and genetic factors as part of the disease multifactorial etiology5,6. In those MCI cases destined to evolve to Alzheimer's Disease, this “window” is an opportunity to develop biomarkers that help to identify etiology and predict progression.
Our study is motivated by the fact that the Apolipoprotein E isoform E4 (ApoE4) is the best-established genetic risk factor for AD7. Among MCI ApoE4 Carriers, previous studies have reported an increased risk of developing AD, a younger mean age of onset and more rapid cognitive decline than non-Carriers8. Likewise, in MCI, the prevalence of this genotype is substantially higher than in control individuals9. The ApoE4 mechanisms in AD's pathogenesis are not entirely understood but have been related to amyloid-β-dependent and independent pathways10. Although the amount of evidence linking ApoE4 with cognitive deficits, morphological, structural, and functional brain alterations during AD progression11,12 at this point, it is still unclear how this genetic risk factor impairs the brain networks organization.
Our study's second motivation is based on previous research supporting the idea of AD being a disconnection syndrome, which disrupts higher-order neuronal networks13. In this context, using a network-based approach is critical to understand brain alterations and cognitive deficits during the disease progression. One feasible mathematical approach to elucidate the AD impact on brain networks is the graph formalism14. In graph theory terms, our brain is studied as a model to describe some essential elements -nodes- (brain regions) and the relationship between them (edges). Afterward, the brain complex covariance patterns are translated into global and regional graph metrics15. During the last decade, the graph analysis has been applied to characterize the brain structural covariance in AD and MCI16. It is based on the phenomenon that regions correlated in morphometric descriptors (i.e., cortical thickness) are often part of the same brain system that subserve specific behavioral and cognitive functions17. The mechanisms underlying these coordinated patterns seem to be related to mutually trophic effects, common pathological vulnerabilities, and genetic factors16.
Following this modeling approach, studies using different neuroimaging modalities have shown aberrant brain network properties in AD, MCI, and preclinical states18. They revealed disease-related network alterations such as a loss of balance between segregation and integration of information (small-world attribute) and redistribution of regions considered central for the information flux over the network (hub regions)19,20,21,22,23. Additionally, Alzheimer's patients show decreased long-distance-interhemispheric correlations- and increased correlations between brain regions targeted by the disease18,19,23. These disruptions could reflect that the whole-brain network is more segregated and less integrated during AD progression than in healthy individuals. Despite such findings, the ApoE4 risk factor's inclusion has been scarce and limited mostly to healthy aging subjects and AD patients24,25,26,27,28.
There is only a handful of investigations on the ApoE4 effects on topological brain networks organizations in MCI. Two studies using resting-state Functional Magnetic Imaging (rs-fMRI) and diffusion weight imaging (DWI) compared MCI Carrier and non-Carriers groups29,30. In both cases, the network analysis showed specific aberrant patterns in MCI Carriers. Yao and colleagues31 reported for the first time differences between Carriers and non-Carriers based on metabolic covariance networks using Fluorodeoxyglucose Positron Emission Tomography (FDG-PET). Carriers were found to have lower clustering index and disruptive long-distance interregional correlations.
Nevertheless, ApoE4-related effects on the structural covariance network topology have not yet been fully explored in MCI. Such work is necessary to clarify how the genetic risks mediate and constrain the covariance patterns and the phenotypic expression in MCI. The identification of these subtle alterations at the network level may help detect, at earlier stages, the risk of AD progression in MCI ApoE4 Carriers compared to other disease-related markers like atrophy.
Precisely, we focus on the ApoE4-related modulation of the topological organization of cortical thickness covariance brain networks in MCI through structural MRI (sMRI) and graph-theory approach. We examine different features of the structural brain topology: (1) regional cortical thickness, (2) global network attributes (clustering index, characteristic path length, local and global efficiency, global connectivity, and homologous region connectivity) (3) nodal properties (normalized betweenness centrality, hubs) (4) network community detection (modularity) and resilience to insults (target attack). We hypothesize that ApoE4 is related to both local and global network properties changes in MCI.
Materials and methods
Data used in the preparation of this article were obtained from the Alzheimer's Disease Neuroimaging Initiative (ADNI) database (adni.loni.usc.edu). The ADNI was launched in 2003 as a public–private partnership, led by Principal Investigator Michael W. Weiner, MD. ADNI's primary objective has been to test whether serial magnetic resonance imaging, positron emission tomography, other biological markers, and clinical and neuropsychological assessment can be combined to measure the progression of MCI and early Alzheimer’s Disease. For up-to-date information about ADNI, including Police and Procedures, see www.adni-info.org.
In the present study, 253 MCI participants with baseline T1-weighted structural magnetic resonance images were selected and downloaded from the USC's Laboratory of Neuroimaging ADNI (http://www.loni.ucla.edu/ADNI/).
The inclusion criteria were as follows: Mini-Mental-State-Examination (MMSE) scores between 24 and 30 (inclusive), a memory complaint, objective memory loss measured by education adjusted scores on the Wechsler Memory Scale Logical Memory II, a Clinical Dementia Rating (CDR) of 0.5, and absence of significant levels of impairment in other cognitive domains, essentially preserved activities of daily living and an absence of dementia.
Exclusion criteria included: (1) the presence of a major depressive disorder or significant symptoms of depression; (2) modified Hachinski ischemia score greater than 5; (3) significant neurological or psychiatric illness; (4) use of antidepressant drugs with anticholinergic side effects; (5) high dose of neuroleptics, chronic sedatives, hypnotics, antiparkinsonian medication, and use of narcotic analgesics. Detail about inclusion/exclusion criterium can be found in http://adni.loni.usc.edu/wp-content/themes/freshnewa-dev-v2/clinical/ADNI-1_Protocol.pdf)32.
The MCI group was stratified into those with one ApoE4 allele (Carriers) and those without (non-Carriers). ApoE genotyping details can be accessed at http://adni.loni.usc.edu/data-samples/clinical-data/33. Participants with one or more E2 allele(s) were excluded from this study due to the allele's possible protective effects34.
The subjects also met the following criteria: anatomical study acquired in a 1.5 T MRI-scanner, right-handedness, high sMRI image quality. For biomarker's measurements (Cerebrospinal fluid) characteristics, see Supplementary Information.
As per ADNI protocols, all procedures performed in studies involving human participants were under the institutional national research committee's ethical standards and the 1964 Helsinki declaration and its later amendments or comparable ethical standards. More details can be found at adni.loni.usc.edu. Participants were studied under ADNI protocols approved by the Institutional Review Board (IRB) at each recruitment site, and written informed consent was obtained from all subjects prior to enrollment. A listing of sites with named Site Investigators can be found online at http://adni.loni.usc.edu/wp-content/themes/freshnews-dev-v2/documents/policy/ADNI_Acknowledgement_List%205-29-18.pdf.
Data acquisition and preprocessing
Preprocessed versions of the 253 baselines T1-weighted MRI scans were downloaded. Further details are available in the ADNI-MRI technical procedures manual (http://adni.loni.usc.edu/methods/documents/MRI protocols). Preprocessing steps can be found elsewhere35,36,37.
Computation of mean cortical thickness matrices
Cortical reconstruction and volumetric segmentation were performed using the Freesurfer analysis software suite with default settings (http://adni.loni.usc.edu/methods/documents/MRI protocols). The technical details of these procedures have been previously described38. FreeSurfer provides the cerebral cortex's parcellation based on Destrieux sulci-gyral-based atlas39 and the mean cortical thickness for each cortical structure. We used these outputs to construct our data matrices for each group. The number of rows corresponds to the number of subjects, while the number of columns corresponds to the number of structures (Fig. 1).
Cortical thickness network construction
We defined a connection as statistical associations in cortical thickness between each pair of brain regions for a parcellation scheme of N = 148 anatomical structures (subcortical gray nuclei were excluded) (Supplementary Table S1 online). The synchronized covariations in cortical thickness between two regions were computed using Pearson's correlation coefficient across subjects. Thus, the interregional correlation matrix (N × N, N is the number of brain regions) of such connections was obtained using all pairs of anatomical structures. Self-connections were excluded implying zeros in the diagonal of the symmetric matrix. It is essential to point out that a partial correlation analysis could not be used in our case because the sample size was not large enough for a robust estimation of this measure.
Before the correlation analysis, a linear regression was performed at every region to remove the effects of age, gender, age-gender interaction, and cerebral mean cortical thickness.
In the next step, we obtained for each MCI group Nboot = 2000 bootstrap samples of the connectivity matrix by selecting a random subset of subjects with replacement using the classical bootstrapping procedure described in40.
The connectivity matrices obtained from bootstrapping were thresholded to create sparse binary graphs. We explored the Network Properties of the graphs over a range of sparsity degrees varied from 0.5 to 0.9 in steps of 0.0241. This range of sparsity degree has been indicated in previous studies to be optimal42,43. Similarly to other papers, only the positive correlation values are used to define the connectivity matrices. This choice is based on the lack of a clear physiological justification for negative correlations and the possible contamination by spurious negative correlation as a side effect of regressing out global effects in the preprocessing step (Fig. 2).
Network properties analysis, graph theory approach
In general, a complex network can be represented as a graph G = [N, K], the components of this system are called nodes (N), and the relations or connections between them are called edges (K)44. The nodes are the anatomical regions, and the edges are the correlations in cortical thickness across subjects between pairs of these brain regions. It is important to note here that this is a mathematically derived network whose connections do not necessarily constitute brain functional or physiological mechanisms directly. However, these networks are based on structural data. Therefore, they indirectly reflect the underlying mechanism, allowing us at the same time to use them and their properties as possible biomarkers of the differences between normal and pathological brain states.
In particular, we analyzed the following global network attributes: clustering index45, characteristic path length44,45, local and global efficiency46, global connectivity, and homologous regions connectivity47. To describe the network's nodal properties, we computed the normalized betweenness centrality (NBC)19,23 measure to identify the network hubs. We also performed a modularity analysis representing a network with densely interconnected nodes and relatively few connections between nodes in different modules48. It is a reflection of the natural segregation within a network49,50,51. Additionally, we carried out a 'Targeted-Attack' study to evaluate the cortical thickness covariance network's resilience when the most critical regions (hubs) are virtually attacked. Definitions for these measures within the traditional interpretation of complex networks framework52 can be found in Supplementary Information and Table S2 online.
Methodology for studying differences in regional cortical thickness
Cortical vertex-wise regression analyses were performed using the SurfStat MATLAB toolbox (http://www.math.mcgill.ca/keith/surfstat). Age, gender, and mean cortical thickness (CT) were statistically controlled. The statistical significance of the t-statistic maps for cortical thickness differences was corrected for multiple comparisons using Random Field Theory (RFT) to avoid false positives when more than 80,000 tests were performed53. RFT identifies statistically significant "clusters" of vertices and vertex "peaks". Cluster p-values show regions of connected vertices with p-values below 0.001 in clusters whose extent is significant at p < 0.05, i.e., a collection of connected vertices with p < 0.001 that was unlikely to occur by chance.
Statistical methods to study ApoE4 modulation of global network properties
Network properties (NP) of the cortical thickness correlation matrices were computed for each sparsity degree values and different bootstrap samples in each MCI group. Thus, we had a set of Nboot = 2000 NP curves for each network property. The area under the curve (AUC) was computed for each network attribute to contrast the global behavior of these attributes54. The NP curves' monotonic changes make AUC a suitable descriptor of the networks' global performance.
We followed three main steps to examine differences in global network properties between groups: (1) construction of the empirical bootstrapped distribution of differences by subtracting the corresponding bootstrap samples between groups; (2) definition of the statistical significance level: a 95 percent confidence interval (CI) (biased corrected percentile bootstrap CI)55 of the distribution of the empirical difference is estimated; (3) Hypothesis testing: a significant difference between groups is accepted if CI does not contain zero, no significant difference is considered otherwise. A p-value associated with each hypothesis test is also reported.
Methodology to explore nodal betweenness centrality (NBC) differences between groups
For each bootstrap sample of the cortical thickness connectivity matrix, the NBC was computed at every single sparsity degree. Previously to this process, the largest component54 of all bootstrap samples of the cortical thickness covariation matrices were calculated. The minimum sparsity degree for the largest connected components (equal to the number of structures) was used as an upper limit of the sparsity degree range. This step guarantees that all nodal NBCs come from fully connected cortical thickness networks. Similarly to global network properties, we take the AUC and follow the three main steps to examine differences between groups for each anatomical structure. To control for multiple comparisons (across the number of structures), we applied the False Discovery Rate (FDR) correction.
Hubs were selected as those with mean NBC superior to 1.5, similar to41.
Construction of the Cortical Thickness Network and computation of network metrics were performed using the MorphoConnect toolbox56 and subroutines of the Brain Connectivity Toolbox52 (https://sites.google.com/site/bctnet/). The figures were created using the BrainNet Viewer package57 (http://www.nitrc.org/projects/bnv) and the Gephi package58 (https://gephi.org/).
Demographic and neuropsychological variables
There were no significant differences in gender, education, MMSE scores, and mean cortical thickness between groups (Table 1). However, the age was significantly different between MCI Carriers compared to non-Carriers (U (6542) = − 2.51, p = 0.01). The MCI Carriers group was younger than non-Carriers on the diagnosis age (74.17 vs. 76). This result agrees with previous studies were ApoE4 had been associated with a younger age of onset59.
ApoE4-related changes in regional cortical thickness
Differences in cortical thickness between MCI Carriers and non-Carriers were not statistically significant after FDR correction (Supplementary Fig. S1 online). However, percent difference maps show trends for a reduced thickness bilaterally in the anterior temporal lobe and frontal lobe regions in the Carriers group compared with non-Carriers. The non-Carriers group tended to lower cortical thickness values in left posterior parietal areas, the precuneus, posterior cingulate gyrus, and frontal pole. For a list of clusters, see Supplementary Table S3 online.
ApoE4 modulates the global network properties
Figure 3 shows the cortical thickness matrices for negative (Fig. 3a,b) and positive correlation values (Fig. 3c,d) for each group. Only matrices with positive values were used for the subsequent analysis.
Figure 4 shows the changes in global network properties for both groups across various densities thresholds (0.5 to 0.9). The two networks exhibit differences in clustering index, characteristic path length, local and global efficiency, global connectivity, homologous regions connectivity, and modularity. The Target Attack simulation was not significantly different between groups (p > 0.05) for the whole range of densities values (Table 2).
The comparison of the global network properties based on the AUC values revealed in MCI Carriers as compared with non-Carriers a decrease in clustering index, characteristic path length, local efficiency, homologous regions connectivity, global connectivity strength, and modularity. In contrast, the MCI Carriers group exhibited higher global efficiency (Fig. 5). The results of the statistical analysis, including confidence intervals, can be found in Table 2.
Group-based differences in normalized betweenness centrality (NBC)
We also studied the effects of ApoE4 on the Normalized Betweenness Centrality (NBC), a regional network property. The AUC analysis showed 11 regions with NBC differences between groups after FDR correction (p < 0.05) (Fig. 6). The full list of structures and the statistical analysis results (including confidence intervals) can be found in Supplementary Table S4 online. NBC regional differences between groups comprise mainly occipital-temporal brain areas followed by limbic and frontal regions. Compared with non-Carriers, Carriers showed lower NBC for all brain regions except for the right lingual gyrus, left inferior temporal sulcus, right medial occipitotemporal sulcus (collateral sulcus), and lingual sulcus.
ApoE4 modifies the brain network hubs
We also studied the effects on the hubs of the cortical thickness covariance network due to the presence of ApoE4. There were identified 24 hubs in each group (Fig. 7). The detailed list of structures and its NBC values were tabulated in Supplementary Table S5 online. We identify 11 common hubs to both groups (Fig. 7, yellow structures), including limbic (bilateral anterior part of the cingulate gyrus and sulcus, left posterior-dorsal part of the cingulate gyrus), insular (bilateral posterior ramus of the lateral sulcus, anterior segment of the circular sulcus of the insula), frontal (central operculum and sulci), temporal (superior temporal sulcus) and temporal-occipital and parietal-occipital regions (parieto-occipital sulcus, anterior transverse collateral sulcus).
Compared to non-Carriers, where hubs comprised mainly parietal-occipital-temporal areas, in the Carriers group were localized predominantly in frontal and parietal-occipital-temporal regions. Hub regions found only in Carriers, including the posterior-dorsal part of the cingulate gyrus, inferior occipital gyrus and sulcus, superior temporal and orbital gyrus. Areas identified as hubs in the non-Carriers comprised the lingual aspect of the medial occipitotemporal gyrus, supramarginal gyrus, and subcallosal gyrus.
ApoE4-related change of the cortical thickness network modularity
Modularity estimation was performed on the groups averaged connectivity matrix using Newman's metric. The resulting analysis (Fig. 8) divided the 148 cortical nodes into five modules for MCI Carriers and three modules in the non-Carriers group.
The modules are represented on a circular graph layout, where the nodes are placed in circles if they belong to the same module. Three communities defined the non-Carriers modularity with similar region numbers (community 1: N = 41, community 2: N = 59, and community 3: N = 48). Each module included a distributed set of regions. However, the analysis per lobule showed an anterior community based mainly in the frontal areas, a central module with similar frontal, parietal and occipital regions, and a posterior module integrated by temporal and temporal-occipital areas. On the other hand, Carriers showed more segregated modularity based on 5 communities with two large modules (community 2: N = 33 and community 3: N = 39) and three smaller ones (community 1: N = 30, community 4: N = 22, and community 5: N = 24). In this group, the community composition was more diverse as compared with non-Carriers. However, we were able to identify that the modules showed a specific pattern of regions summarized as follows: community (1) temporal-occipital, community (2) frontoparietal, community (3) parietal-occipital, community (4) insula, community (5) frontal regions. For a complete list of regions per module in each group, see Supplementary Table S6 online.
It is worth noting that modules 2 and 3 in Carriers are assigned to the second module in non-Carriers and modules 4 and 5 to module 3, suggesting a low level of segregation for non-Carriers. The sub-modules combine to form predominantly anterior–posterior large communities.
We investigated for the first time the cortical thickness structural covariance networks in ApoE4 Carriers and non-Carriers groups to assess the effect of genetic risk on large-scale network topology in MCI. Few previous studies have found evidence of the ApoE4 modulation on the MCI brain network topology using graph theory based on physiological variables derived from other image modalities (rs-fMRI, FDG-PET, and DWI). However, our approach is timely based on the following points:
As a morphometric descriptor, cortical thickness offers unique information about morphological covariance patterns between brain regions compared to other cortical measures41.
Structural covariance analysis is attractive because of the wide availability (in clinical and research settings) of high-quality sMRI scans compared with other modalities. Additionally, the cortical thickness derived from sMRI has proved consistent across scanner systems and field strengths60.
It has been shown that anatomical covariance patterns are related to functional and anatomical connectivity. However, comparing these connectivity measures has demonstrated that brain structural covariance networks capture complementary information of the same physiological processes16,61.
Graph theory provides a unique description of the multivariate neural process by looking at their local and global connectivity topology.
Unlike the previous studies29,30,31, we introduced the modularity and target attack analyses providing further information about the topological organization of the structural covariance networks in MCI.
Summarizing, our research presents novel experimental evidence regarding the ApoE4 effects on the brain network topology, which are worth investigating to define intermediate phenotypes in MCI.
In general, our findings revealed a decrease in global and homologous connectivity strength, clustering index, characteristic path length, local efficiency, modularity, and an increase of global efficiency in MCI Carriers compared to non-Carriers. MCI carriers showed lower values of NBC in several brain regions. Together, these findings concur with the evidence that ApoE4 is associated with an aberrant brain network topology in MCI. On the other hand, the changes are not detectable with the standard univariate approach based on the cortical thickness's differences. Our results support the concept that multivariate measures (i.e., covariations) combined with a graph theoretical approach are more sensitive to identifying complex pathological processes, as found in other brain diseases. Univariate measures derived from the standard methods could be insufficient for capturing subtle (early) abnormal changes.
Some of these results deserve more attention and will be discussed in the following.
In particular, we observed a decrease in the clustering coefficient index in MCI Carriers relative to non-Carriers, indicating lower local cortical thickness correlations. This finding suggests a topological organization more like a random network in this group of patients, a structure previously reported in AD subjects18,62,63. Moreover, it has been demonstrated an association between longitudinal decreases of the clustering index and risk of MCI conversion into AD63. Previous studies showed no differences between groups or reported similar results29,31. The disagreement between investigations could be related to several factors like group composition, sample size, different neuroimaging modalities, and atlas parcellation.
In the current study, we also observed a shorter characteristic path length associated with the presence of the ApoE4, indicating that fewer steps are required to carry on the information across remote brain regions64. A similar result was found in previous research in cognitively normal elderly ApoE4 Carriers26 using FDG-PET. A compensatory mechanism for early local pathological events seems a plausible hypothesis when the clustering index decreases in the presence of shorter characteristic path length. Also, the ApoE4 allele has been proposed as an example of antagonistic pleiotropy65. The concept means that ApoE4 may offer benefits during early and middle age and promote better compensatory mechanisms during early disease phases like MCI that can be captured using a complex network approach.
Like in the clustering index, one previous study reported no differences between groups in characteristic path length31. However, our results seem to be more reliable since Yao et al. (2015) gathered the MCI, AD, and healthy controls to form the Carriers and non-Carriers groups, making it challenging to disentangle group differences31.
Our analysis also showed a decrease in global connectivity strength- an aggregate measure of the correlation values between all possible pairwise anatomical structures- in MCI Carriers relative to non-Carriers. Previous studies did not report on this network property29,30,31. This finding may indicate that mechanisms underlying cortical thickness are differentially coordinated across this group of patients. Another possibility is that ApoE4 increases the interindividual differences between regional cortical thicknesses in Carriers. It may be due to less cortical thickness coordinated patterns concerning the homogeneity effects created by putative compensatory and shared brain region vulnerability associated with the aging processes and interactions with the MCI stage.
The nodal properties results allowed us to generate hypotheses about the ApoE4 impact on brain network integration and segregation in MCI. Similar to previous studies, we found the opposite effects of the ApoE4 genotype on nodal centrality30,31. There is probably more than one cause for these alterations, which makes disease-related changes in structural covariance challenging to interpret. A regional lower NBC may be suggestive of dysconnectivity due to a localized degeneration. By contrast, an increase may indicate over connectivity or synchronized cortical thickness loss in several areas targeted by the same neurodegenerative process. Most brain regions reported here are different from previous studies30,31 based on other neurophysiological variables. It is indicative that the networks of cortical thickness covariance capture supplementary information of the anatomical brain organization. Other factors could also be playing a role like sample characteristics and different statistical approaches.
Our findings showed agreements with previous studies in AD neurodegeneration. The fact that crucial structures like Posterior Cingulate Cortex (PCC) showed lower NBC values in the Carriers group suggests that regional topological properties may capture disease-related effects that can be further explored in association with the risk of AD progression. We identified between-group differences in NBC across different lobes, consistent with previous findings26,30. Several regions in the Limbic and Frontal cortex decreased centrality in Carriers as compared with non-Carriers. Notably, for all detected hubs, NBC was lower in Carriers than non-Carriers. Some of these structures were: cingulate gyrus, middle occipital gyrus, occipital pole, superior frontal sulci, and orbital gyrus. It is important to note that several of these regions are part of the Default Mode Network (DMN). As is recognized, the DMN is involved in self-referential functions such as episodic memory66 affected by AD. In this network, the PCC is a key integration node between the medial temporal lobe and medial prefrontal subsystems66,67. Previous studies reported in the DMN (including PCC) high glycolytic metabolism, enhancing abnormal amyloid deposition aggregation68,69. ApoE4, as a disrupted metabolic factor10, may alter the DMN resting-state activity and ultimately bringing atrophy in MCI ApoE4 Carriers, accelerating AD pathology early during the disease course.
Lower NBC values were also found in regions that belong to the Saliente Network (i.e.insula). This network operates on identified salience and, as such, includes known sites for sustained attention and working memory (dorsolateral prefrontal cortex, lateral parietal cortex), response selection (dorsomedial frontal), and response suppression (prefrontal cortex)70,71,72. Our findings may suggest that ApoE4 Carriers have altered regulation of control processes that subsequently influence memory performance.
To the best of our knowledge, we reported, for the first time, a modularity analysis of the structural covariance network in MCI. We observed a decreased modularity in Carriers as compared with non-Carriers. A less modular network implies fewer connections within modules and more connections to other modules. In graph theory terms, Carriers shows better cost-efficiency wiring regarding the physical volume occupied, conduction delay, and metabolic cost. On the other hand, the increase of interconnectedness between modules can lead to the rapid spreading of disease pathological markers (neurodegenerative process) and loss of specialization73. In many networks, as in our case, modularity and global efficiency are inversely related, as a highly modular topology could require long communication paths to integrate information across the network.
In addition to these differences, the module size and composition also change associated with the ApoE4. This analysis revealed in Carriers a spatial rearrangement of these communities. They include sets of brain regions that are anatomically proximal, and they mainly belong to the same lobule. However, in non-Carriers, the module's compositions are more distributed across the cortex. We identified anterior-medial-posterior network modularity mainly formed by frontal, frontal-parietal, and temporal-occipital modules. This modular topology has been described previously in resting-state networks in normal aging. It evidences the brain network evolves from a preferentially local connectivity pattern to a more distant and functionally community structure74. Further longitudinal studies on modularity patterns differences between Carriers and non-Carriers could offer an exciting opportunity to distinguish those MCI patients at high risk of AD progression.
In conclusion, our study applies the graph theory to assess the ApoE4-related changes on global and local network topology in MCI based on the concurrent variations of the cortical thickness across anatomical structures. Our findings showed that some network properties changes in MCI Carriers seem to be associated with altered communication between neighboring regions. It may be an early response to AD-related pathological markers (i.e., tau-tangles and amyloid-beta plaques depositions). On the other hand, a better global network communication could be considered the expression of compensatory/degeneracy mechanisms to sustain the transmission of the information across distant brain regions associated with the genetic challenge. These changes in topological attributes may be considered sensitive markers to detect early brain network changes related to the disease progression.
The methodological approach used in this study has several limitations. The structural covariance analysis has a static nature. Evidence suggests that the brain undergoes spontaneous reconfiguration at a temporal scale75, as such properties like modular structure and hub may fluctuate over time. A quantitative comparison of the network topological attributes between studies is difficult. These properties' values depend on experimental parameters like brain parcellation, nodes-edge definitions, and sample size76. Despite providing useful information, structural covariance analysis is a group approach. It does not allow individual analysis and statistical associations between topological network attributes and clinical/cognitive measures.
Other aspects need to be addressed in future investigations. (1) MCI patients exhibit different progression trajectories that we did not consider here; accordingly, further follow-up longitudinal studies are warranted to examine the interaction between network properties, disease progression, and ApoE4 (2) The inclusion of healthy elderly sample, as well as AD patients, would help to fully characterize the ApoE4 effect on the brain network properties across the disease spectrum (4) This study did not investigate whether the ApoE4-related impact on the brain network topology is mediated by pathological disease markers like beta-amyloid and tau deposition. Further investigations on this topic will clarify the underlying mechanisms associated with the brain network properties changes. Despite these limitations, our study sheds light on the structural connectomics of MCI associated with the ApoE4. We considered a complex network analysis with the genetic risk factors inclusion, a valuable approach to understanding the AD spectrum, which could improve the personalized medicine perspective.
Data used in the preparation of this article were obtained from the Alzheimer's Disease Neuroimaging Initiative (ADNI) database (adni.loni.usc.edu). ADNI database is publicly accessible from adni.loni.usc.edu upon request. ADNI's primary goal has been to test whether serial MRI, PET, other biological markers, and clinical and neuropsychological assessment can be combined to measure the progression of mild cognitive impairment and early Alzheimer's Disease. The Principal Investigator of ADNI is Michael W. Weiner, MD (email: Michael.Weiner@ucsf.edu).
2020 Alzheimer’s disease facts and figures. Alzheimer’s Dementia 16, 391–460 (2020)
Albert, M. S. et al. The diagnosis of mild cognitive impairment due to Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease. Alzheimer’s Dementia 7, 270–279 (2011).
Jansen, W. J. et al. Prevalence of cerebral amyloid pathology in persons without dementia: A meta-analysis. JAMA 313, 1924–1938 (2015).
Mueller, S. G. et al. Ways toward an early diagnosis in Alzheimer’s disease: The Alzheimer’s Disease Neuroimaging Initiative (ADNI). Alzheimer’s Dementia 1, 55–66 (2005).
Gao, W. et al. Intersubject variability of and genetic effects on the Brain’s functional connectivity during infancy. J. Neurosci. 34, 11288–11296 (2014).
Petersen, R. C. Mild cognitive impairment: Transition between aging and Alzheimer’s disease. Neurologia (Barcelona, Spain) 15, 93–101 (2000).
Rao, A. T., Degnan, A. J. & Levy, L. M. Genetics of Alzheimer disease. AJNR Am. J. Neuroradiol. 35, 457–458 (2014).
Farlow, M. R. et al. Impact of APOE in mild cognitive impairment. Neurology 63, 1898–1901 (2004).
Norberg, J. et al. Regional differences in effects of APOE ε4 on cognitive impairment in non-demented subjects. Dement. Geriatr. Cogn. Disord. 32, 135–142 (2011).
Liu, C.-C., Liu, C.-C., Kanekiyo, T., Xu, H. & Bu, G. Apolipoprotein E and Alzheimer disease: Risk, mechanisms and therapy. Nat. Rev. Neurol. 9, 106–118 (2013).
Liu, Y., Cai, Z.-L., Xue, S., Zhou, X. & Wu, F. Proxies of cognitive reserve and their effects on neuropsychological performance in patients with mild cognitive impairment. J. Clin. Neurosci. 20, 548–553 (2013).
Cherbuin, N., Leach, L. S., Christensen, H. & Anstey, K. J. Neuroimaging and APOE genotype: A systematic qualitative review. Dement. Geriatr. Cogn. Disord. 24, 348–362 (2007).
Delbeuck, X., Van der Linden, M. & Collette, F. Alzheimer’ disease as a disconnection syndrome?. Neuropsychol. Rev. 13, 79–92 (2003).
Xie, T. & He, Y. Mapping the Alzheimer’s brain with connectomics. Front. Psychiatry 2, 1–14 (2012).
Bullmore, E. T. & Bassett, D. S. Brain Graphs: Graphical models of the human brain connectome. Annu. Rev. Clin. Psychol. 7, 113–140 (2011).
Alexander-Bloch, A., Giedd, J. N. & Bullmore, E. Imaging structural co-variance between human brain regions. Nat. Rev. Neurosci. 14, 322–336 (2013).
Lerch, J. P. et al. Mapping anatomical correlations across cerebral cortex (MACACC) using cortical thickness from MRI. NeuroImage 31, 993–1003 (2006).
Tijms, B. M. et al. Alzheimer’s disease: Connecting findings from graph theoretical studies of brain networks. Neurobiol. Aging 34, 2023–2036 (2013).
He, Y., Chen, Z. & Evans, A. Structural insights into aberrant topological patterns of large-scale cortical networks in Alzheimer’s disease. J. Neurosci. 28, 4756–4766 (2008).
Lo, C.-Y. et al. Diffusion tensor tractography reveals abnormal topological organization in structural cortical networks in Alzheimer’s disease. J. Neurosci. 30, 16876–16885 (2010).
Stam, C. J., Jones, B. F., Nolte, G., Breakspear, M. & Scheltens, P. Small-world networks and functional connectivity in Alzheimer’s disease. Cereb. Cortex 17, 92–99 (2007).
Supekar, K., Menon, V., Rubin, D., Musen, M. & Greicius, M. D. Network analysis of intrinsic functional brain connectivity in Alzheimer’s disease. PLoS Comput. Biol. 4, e1000100 (2008).
Sanabria-Diaz, G., Martínez-Montes, E. & Melie-Garcia, L. Glucose metabolism during resting state reveals abnormal brain networks organization in the Alzheimer’s disease and mild cognitive impairment. PLoS ONE 8, e68860 (2013).
Brown, J. A. et al. Brain network local interconnectivity loss in aging APOE-4 allele carriers. Proc. Natl. Acad. Sci. USA 108, 20760–20765 (2011).
Goryawala, M., Duara, R., Loewenstein, D. A., Zhou, Q. & Barker, W. Apolipoprotein-E4 ( ApoE4) carriers show altered small-world properties in the default mode network of the brain. Biomed. Phys. Eng. Express 1, 15001 (2015).
Seo, E. H. et al. Influence of APOE genotype on whole-brain functional networks in cognitively normal elderly. PLoS ONE 8, 2–10 (2013).
Wang, J., Wang, X., He, Y., Yu, X. & Wang, H. Apolipoprotein E e 4 modulates functional brain connectome in Alzheimer’s disease. Hum. Brain Mapp. 36, 1828–1846 (2015).
Zhao, X. et al. Disrupted small-world brain networks in moderate Alzheimer’s disease: A resting-state fMRI study. PLoS ONE 7, e99540 (2012).
Ma, C. et al. Disrupted brain structural connectivity: Pathological interactions between genetic APOE ε4 status and developed MCI condition. Mol. Neurobiol. 54, 6999–7007 (2017).
Wang, Z. et al. APOE genotype effects on intrinsic brain network connectivity in patients with amnestic mild cognitive impairment. Sci. Rep. 7, 397 (2017).
Yao, Z. et al. A FDG-PET study of metabolic networks in apolipoprotein E ε4 allele carriers. PLoS ONE 10, 1–16 (2015).
Petersen, R. C. et al. Alzheimer’s Disease Neuroimaging Initiative (ADNI): Clinical characterization. Neurology 74, 201–209 (2010).
Saykin, A. J. et al. Alzheimer’s disease neuroimaging initiative biomarkers as quantitative phenotypes: Genetics core aims, progress, and plans. Alzheimer’s Dementia 6, 265–273 (2010).
Serrano-Pozo, A., Qian, J., Monsell, S. E., Betensky, R. A. & Hyman, B. T. APOEε2 is associated with milder clinical and pathological Alzheimer disease. Ann. Neurol. 77, 917–929 (2015).
Jovicich, J. et al. Reliability in multi-site structural MRI studies: Effects of gradient non-linearity correction on phantom and human data. NeuroImage 30, 436–443 (2006).
Fornito, A. et al. Variability of the paracingulate sulcus and morphometry of the medial frontal cortex: Associations with cortical thickness, surface area, volume, and sulcal depth. Hum. Brain Mapp. 29, 222–236 (2008).
Sled, J. G., Zijdenbos, A. P. & Evans, A. C. A nonparametric method for automatic correction of intensity nonuniformity in MRI data. IEEE Trans. Med. Imaging 17, 87–97 (1998).
Fischl, B. et al. Automatically parcellating the human cerebral cortex. Cereb. Cortex 14, 11–22 (2004).
Destrieux, C., Fischl, B., Dale, A. & Halgren, E. Automatic parcellation of human cortical gyri and sulci using standard anatomical nomenclature. NeuroImage 53, 1–15 (2010).
Efron, B. & Tibshirani, R. An Introduction to the Bootstrap (Chapman & Hall, New York, 1994).
Sanabria-Diaz, G. et al. Surface area and cortical thickness descriptors reveal different attributes of the structural human brain networks. NeuroImage 50, 1497–1510 (2010).
He, Y., Chen, Z. J. & Evans, A. C. Small-world anatomical networks in the human brain revealed by cortical thickness from MRI. Cereb. Cortex 17, 2407–2419 (2007).
Achard, S. & Bullmore, E. Efficiency and cost of economical brain functional networks. PLoS Comput. Biol. 3, 0174–0183 (2007).
Boccaletti, S., Latora, V., Moreno, Y., Chavez, M. & Hwang, D. Complex networks: Structure and dynamics. Phys. Rep. 424, 175–308 (2006).
Watts, D. J. & Strogatz, S. H. Collective dynamics of ‘small-world’ networks. Nature 393, 440–442 (1998).
Latora, V. & Marchiori, M. Efficient behavior of small-world networks. Phys. Rev. Lett. 87, 198701 (2001).
Freeman, L. C. A set of measures of centrality based on betweenness. Sociometry 40, 35 (1977).
Castellano, C., Cecconi, F., Loreto, V., Parisi, D. & Radicchi, F. Self-contained algorithms to detect communities in networks. Eur. Phys. J. B 38, 311–319 (2004).
Newman, M. & Girvan, M. Finding and evaluating community structure in networks. Phys. Rev. E 69, 26113 (2004).
Buldú, J. M. et al. Reorganization of functional networks in mild cognitive impairment. PLoS ONE 6, 1–8 (2011).
Daianu, M. et al. In Algebraic Connectivity of Brain Networks Shows Patterns of Segregation Leading to Reduced Network Robustness in Alzheimer’s Disease BT: Computational Diffusion MRI (eds O’Donnell, L. et al.) 55–64 (Springer International Publishing, Berlin, 2014).
Rubinov, M. & Sporns, O. Complex network measures of brain connectivity: Uses and interpretations. NeuroImage 52, 1059–1069 (2010).
Chung, M. K. et al. Cortical thickness analysis in autism with heat kernel smoothing. NeuroImage 25, 1256–1265 (2005).
He, Y. et al. Impaired small-world efficiency in structural cortical networks in multiple sclerosis associated with white matter lesion load. Brain 132, 3366–3379 (2009).
Efron, B. The Jackknife, the Bootstrap and Other Resampling Plans (Society for Industrial and Applied Mathematics, Philadelphia, 1982).
Melie-Garcia, L., Sanabria-Diaz, G., Iturria-Medina, Y., Alemán-Gómez, Y. MorphoConnect: toolbox for studying structural brain networks using morphometric descriptors. In 16th Annual Meeting of the Organization for Human Brain Mapping (2010).
Xia, M., Wang, J. & He, Y. BrainNet viewer: A network visualization tool for human brain connectomics. PLoS ONE 8, e68910 (2013).
Bastian, M., Heymann, S. & Jacomy, M. Gephi : An open source software for exploring and manipulating networks visualization and exploration of large graphs. Icwsm 8, 361–362 (2009).
Verghese, P. B., Castellano, J. M. & Holtzman, D. M. Apolipoprotein E in Alzheimer’s disease and other neurological disorders. Lancet Neurol 10, 241–252 (2011).
Dickerson, B. C. et al. Detection of cortical thickness correlates of cognitive performance: Reliability across MRI scan sessions, scanners, and field strengths. NeuroImage 39, 10–18 (2008).
Gong, G., He, Y., Chen, Z. J. & Evans, A. C. Convergence and divergence of thickness correlations with diffusion connections across the human cerebral cortex. NeuroImage 59, 1239–1248 (2012).
Tijms, B. M. et al. Gray matter networks and clinical progression in subjects with predementia Alzheimer ’ s disease. Neurobiol. Aging 61, 75–81 (2018).
Pereira, J. B. et al. Disrupted network topology in patients with stable and progressive mild cognitive impairment and Alzheimer’s disease. Cereb. Cortex 26, 3476–3493 (2016).
Sporns, O. & Zwi, J. D. The Small World of the Cerebral Cortex 145–162 (Springer, Berlin, 2004).
Tuminello, E. R. & Han, S. D. The Apolipoprotein E antagonistic pleiotropy hypothesis: Review and recommendations. Int. J. Alzheimer’s Dis. 2011, 1–12 (2011).
Buckner, R. L., Andrews-Hanna, J. R. & Schacter, D. L. The brain’s default network: Anatomy, function, and relevance to disease. Ann. N. Y. Acad. Sci. 1124, 1–38 (2008).
Raichle, M. E. et al. A default mode of brain function. Proc. Natl. Acad. Sci. USA 98, 676–682 (2001).
Bero, A. W. et al. Neuronal activity regulates the regional vulnerability to amyloid-β deposition. Nat. Neurosci. 14, 750–756 (2011).
Sun, Z.-W. et al. Decreased cerebral blood flow velocity in apolipoprotein E epsilon4 allele carriers with mild cognitive impairment. Eur. J. Neurol. 14, 150–155 (2007).
Curtis, C. E. & D’Esposito, M. Persistent activity in the prefrontal cortex during working memory. Trends Cogn. Sci. 7, 415–423 (2003).
Lau, H. C., Rogers, R. D. & Passingham, R. E. On measuring the perceived onsets of spontaneous actions. J. Neurosci. 26, 7265–7271 (2006).
Ridderinkhof, K. R., Ullsperger, M., Crone, E. A. & Nieuwenhuis, S. The role of the medial frontal cortex in cognitive control. Science 306, 443–447 (2004).
Salathé, M. & Jones, J. H. Dynamics and control of diseases in networks with community structure. PLoS Comput. Biol. 6, e1000736 (2010).
Fair, D. A. et al. The maturing architecture of the brain’s default network. Proc. Natl. Acad. Sci. USA 105, 4028–4032 (2008).
Calhoun, V. D., Miller, R., Pearlson, G. & Adali, T. The chronnectome: Time-varying connectivity networks as the next frontier in fMRI data discovery. Neuron 84, 262–274 (2014).
Zalesky, A., Fornito, A. & Bullmore, E. T. Network-based statistic: Identifying differences in brain networks. NeuroImage 53, 1197–1207 (2010).
The investigators within the ADNI contributed to the design and implementation of ADNI and/or provided data but did not participate in the analysis or writing of this report. A complete listing of ADNI investigators and affiliations can be found at http://adni.loni.usc.edu/wp-content/uploads/how_to_apply/ADNI_Acknowledgement_List.pdf. ADNI was launched in 2003 as a public-private partnership led by Principal Investigator Michael W. Weiner, MD. ADNI is funded by the National Institute on Aging, the National Institute of Biomedical Imaging and Bioengineering, and through generous contributions from the following: AbbVie, 'Alzheimer's Association; 'Alzheimer's Drug Discovery Foundation; Araclon Biotech; BioClinica, Inc.; Biogen; Bristol-Myers Squibb Company; CereSpir, Inc.; Cogstate; Eisai Inc.; Elan Pharmaceuticals, Inc.; Eli Lilly and Company; EuroImmun; F. Hoffmann-La Roche Ltd and its affiliated company Genentech, Inc.; Fujirebio; GE Healthcare; IXICO Ltd.; Janssen Alzheimer Immunotherapy Research & Development, LLC.; Johnson & Johnson Pharmaceutical Research & Development LLC.; Lumosity; Lundbeck; Merck & Co., Inc.; Meso Scale Diagnostics, LLC.; NeuroRx Research; Neurotrack Technologies; Novartis Pharmaceuticals Corporation; Pfizer Inc.; Piramal Imaging; Servier; Takeda Pharmaceutical Company; and Transition Therapeutics. The Canadian Institutes of Health Research is providing funds to support ADNI clinical sites in Canada. Private sector contributions are facilitated by the Foundation for the National Institutes of Health (www.fnih.org). The grantee organization is the Northern California Institute for Research and Education, and the study is coordinated by the 'Alzheimer's Therapeutic Research Institute at the University of Southern California. ADNI data are disseminated by the Laboratory for Neuro Imaging at the University of Southern California. This study was funded by Janssen Prevention Centre, http://www.janssen.com/janssen-prevention-center. FK and GS received funding from the European Union Seventh Framework Programme (FP7/2007–2013) under grant agreement No 604102 and the European 'Union's Horizon 2020 research and innovation programme under grant agreement No 720270 (HBP SGA1) and the MORPHEMIC Grant (ID: 871643). BD is supported by the Swiss National Science Foundation (NCCR Synapsy, project grants Nr. 32003B_135679, 32003B_159780, and CRSK-3_190185) and the Leenaards Foundation. LREN is very grateful to Roger De Spoelberch and Partridge Foundations for their generous financial support. The authors thank Dr. Borja Rodriguez Herreros and Maya Jastrzębowska for their contributions to this paper's revision.
The authors declare no competing interests.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Sanabria-Diaz, G., Melie-Garcia, L., Draganski, B. et al. Apolipoprotein E4 effects on topological brain network organization in mild cognitive impairment. Sci Rep 11, 845 (2021). https://doi.org/10.1038/s41598-020-80909-7
This article is cited by
Study on the changes of Structural Covariance Network in post-traumatic stress disorder
Brain Imaging and Behavior (2022)
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.